No Data
Is the CRO Concept "Return of the King"? WuXi AppTec aggressively attacks, leading stocks celebrate after performance!
Release the signal?!
GTJA: Continuous iteration of anti-tumor therapies, domestic new drugs welcome breakthroughs.
GTJA focuses on products with significant differentiation advantages and leading companies in innovative segments.
Is the breakthrough path all in AI? Chain pharmacies are facing a wave of closures and an era of low profits.
① In 2024, particularly in the second half of the year, chain pharmacies will face a large-scale wave of closures, and leading chain pharmacies will generally enter a low-profit era. ② AI is also being assigned higher expectations in helping pharmacies reduce costs and increase efficiency. ③ Publicly available large models, due to a lack of support from vertical domain data, are still insufficient to support the actual Business Operation of pharmacies.
ZHONGZHIPHARM (03737.HK) plans to hold a Board of Directors meeting on March 26 to approve the annual performance.
Gelonghui, March 14丨ZHONGZHIPHARM (03737.HK) announced that the Board of Directors will hold a meeting on March 26, 2025 (Wednesday) at Room 10B, 15th Floor, Cable Television Building, 9 Hai Sheng Road, Tsuen Wan, New Territories, Hong Kong, to consider and approve the audited annual performance for the year ending December 31, 2024, and to consider the distribution of the final dividend for the year 2024 (if any).
ZHONGZHIPHARM: NOTIFICATION OF BOARD MEETING
AI and policy are driving forces! Hong Kong pharmaceutical stocks collectively "rebound" with WUXI BIO surging over 14% to lead the Industry.
① What technological breakthroughs have driven the improvement of research and development efficiency in the Biomedical Industry? ② What are the reasons for the leading increase in WuXi's affiliated companies?
